Genematrix진매트릭스
109820 · KOSDAQ · ₩109820 · 진매트릭스
₩1,419▼ ₩13 (0.91%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩11B | ₩10B | ₩9.8B | ₩11B | ₩12B |
| Cost of sales | ₩4.3B | ₩4.2B | ₩4.9B | ₩6.1B | ₩6.2B |
| Gross profit | ₩6.3B | ₩5.8B | ₩4.9B | ₩5.1B | ₩5.9B |
| Operating income | −₩679M | −₩1.6B | −₩2.5B | −₩1.5B | −₩1.2B |
| Net income | −₩1.8B | −₩3.7B | −₩895M | −₩8.1B | −₩988M |
| Net income to shareholders | −₩1.8B | −₩3.7B | −₩895M | −₩8.1B | −₩988M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩27B | ₩28B | ₩31B | ₩32B | ₩40B |
| Current assets | ₩20B | ₩20B | ₩19B | ₩21B | ₩21B |
| Cash and equivalents | ₩2.3B | ₩1.9B | ₩2.2B | ₩4.8B | ₩12B |
| Total liabilities | ₩9.8B | ₩9.2B | ₩8.2B | ₩7.7B | ₩7.2B |
| Current liabilities | ₩4.7B | ₩4.7B | ₩4.5B | ₩5B | ₩5.3B |
| Borrowings | ₩3.6B | ₩3.6B | ₩3.6B | ₩3.6B | ₩3.6B |
| Total equity | ₩17B | ₩19B | ₩23B | ₩24B | ₩32B |
| Shareholders' equity | ₩17B | ₩19B | ₩23B | ₩24B | ₩32B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩1.3B | −₩200M | −₩2.3B | −₩1B | ₩3.2B |
| Capital spending | ₩65M | ₩32M | ₩161M | ₩81M | ₩256M |
| Free cash flow | ₩1.2B | −₩232M | −₩2.5B | −₩1.1B | ₩3B |
Consolidated where available. Amounts in won.
Also known as: Genematrix / 진매트릭스 / 109820 / KRX:109820
Source: KRX statistical information